Brought to you by MedPage Today. 1. Supreme Court Nixes State Suits Against Generics. Makers of generic drugs cannot be sued under state law for side effects of their products, the Supreme Court ruled Monday, angering patients' rights advocates. 2. Parental Focus on Weight Loss May Harm Teens. Parents who engaged their children in discussion about healthy eating habits offered them a protective effect ...

Read more...

Brought to you by MedPage Today. 1. Risk Model May Catch Type 1 Diabetes Early. A threshold based on risk prediction data from a large epidemiological study of type 1 diabetes may help better predict which patients will develop the disease. 2. Drug Combo Beats Step-Up Tx in New T2D. Starting newly-diagnosed type 2 diabetes patients on triple combination therapy rather than progressing step-wise ...

Read more...

Brought to you by MedPage Today. 1. Organ Donors Will Sign Up on Facebook. Despite years of media and public service campaigns appealing for organ donations, donor rates remained static while demand increased -- until Facebook. 2. MRI May Spot Meningitis from Tainted Steroids. A screening MRI may provide early warning of spinal or paraspinal meningitis in patients who received contaminated steroid injections. 3.
Read more...

Brought to you by MedPage Today. 1. Toddlers: TV Snacks Up Risk for Heart Disease. Certain eating behaviors in small children, including chowing down in front of the TV, were significantly associated with a surrogate marker for heart disease later in life. 2. Undocumented Immigrants' Share of Health Bill Relatively Small. Healthcare for unauthorized immigrants accounted for 1.4% of all healthcare spending in ...

Read more...

Brought to you by MedPage Today. 1. NSAID Use Raises Heart Risk in Arthritis. atients with rheumatoid arthritis and other inflammatory musculoskeletal diseases continue to be treated with nonsteroidal anti-inflammatory drugs (NSAIDs), even with their high risk for ischemic heart disease. 2. Mom's Worrying Linked to Kid's Asthma. Adolescents with asthma reported worse symptoms of breathlessness when they had anxious mothers, and the ...

Read more...

Brought to you by MedPage Today. 1. BPA Level Tied to Higher Weight in Girls. In girls ages 9 to 12, a higher urine concentration of the plastic component bisphenol-A (BPA) was more likely to put them in the 90th percentile on weight charts. 2. Brain Imaging May Guide Depression Tx. Responses to psychotherapy versus antidepressant drugs differed according to levels of glucose ...

Read more...

Brought to you by MedPage Today. 1. 2 Pradaxa Doses Beat Warfarin in Afib. Considering both efficacy and safety, both the 110-mg and 150-mg doses of dabigatran (Pradaxa) had a net clinical benefit compared with warfarin in patients with atrial fibrillation. 2. Overweight Women Risk Delivering Baby Early. The risk of preterm delivery increased significantly in women who were overweight or obese at ...

Read more...

Brought to you by MedPage Today. 1. Branded Diabetes Drugs Cost Medicare a Bundle. Medicare could have saved more than a billion dollars in one year alone if the program's spending on brand-name diabetes drugs matched that of the Veterans Administration. 2. Low Blood Sugar, Dementia Set Vicious Cycle in Diabetes. In older patients with diabetes, cognitive impairment increases the risk of hypoglycemia, ...

Read more...

Brought to you by MedPage Today. 1. Low Vitamin D Linked to Hepatitis B. Vitamin D deficiency might be a key player in hepatitis B (HBV) replication. 2. Wrinkles Emerge in SGR Repeal Debate. As Congress inches toward a change in the way physicians are paid under Medicare, an early-stage Republican proposal drew criticism this week for not going far enough. 3.
Read more...

Brought to you by MedPage Today. 1. Off-Label Chemo Common for Mets. Off-label prescribing of chemotherapy agents is common in the metastatic setting and a substantial proportion of it goes beyond National Comprehensive Cancer Network (NCCN)-accepted practice. 2. FDA Panel Starts to Tackle Avandia Safety. A controversial study of the cardiovascular safety of one-time diabetes blockbuster rosiglitazone (Avandia) has proven difficult for FDA ...

Read more...